Search results for "Protection"

showing 10 items of 1623 documents

Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169

2005

The characteristics of the radionuclides (170)Tm and (169)Yb are highly interesting for their use as high dose-rate brachytherapy sources. The introduction of brachytherapy equipment containing these sources will lead to smaller required thicknesses of the materials used in radiation protection barriers compared with the use of conventional sources such as (192)Ir and (137)Cs. The purpose of this study is to determine the required thicknesses of protection material for the design of the protecting walls. Using the Monte Carlo method, transmission data were derived for broad-beam geometries through lead and concrete barriers, from which the first half value layer and tenth value layer are ob…

medicine.medical_specialtyMaterials sciencemedicine.medical_treatmentBrachytherapyBrachytherapyMonte Carlo methodOpticsmedicineHumansRadiology Nuclear Medicine and imagingMedical physicsYtterbiumRadioisotopesRadiationRadiological and Ultrasound Technologybusiness.industryPublic Health Environmental and Occupational HealthRadiotherapy DosageGeneral MedicineBeam transmissionIridium RadioisotopesTransmission (telecommunications)Cesium RadioisotopesThuliumCalibrationDose reductionRadiation protectionbusinessMonte Carlo MethodHalf-value layerRadiation Protection Dosimetry
researchProduct

Japanese, Mediterranean and Argentinean diets and their potential roles in neurodegenerative diseases

2019

Environmental factors are responsible of cellular senescence and processes found in the development of cognitive disorders. The aim of this paper is to compare benefits of the Japanese, Mediterranean, and Argentinian Diet on the onset or prevention of senile dementia (SD) and Alzheimer's Disease (AD). Special focus was on the effects of specific compounds such as polyunsaturated fatty acids (PUFAs), antioxidants, and saturated and trans fatty acids. A high adherence to diets rich in PUFAs, monounsaturated fatty acids (MUFAs) and antioxidants may decrease the risk of developing neurodegenerative diseases ; while the predominance of saturated and trans fatty acids possibly rises it.

medicine.medical_specialtyMediterranean diet030309 nutrition & dieteticsArgentinaCellular senescenceDiseaseBiologySenile dementiaDiet MediterraneanNeuroprotection03 medical and health sciences0404 agricultural biotechnologyJapanAlzheimer DiseaseInternal medicinealzheimer's disease ; neuroprotection ; mediterranean diet ; japanese style diet ; food patternmedicineHumanschemistry.chemical_classification0303 health sciencesMediterranean RegionNeurodegenerative Diseases04 agricultural and veterinary sciences040401 food scienceNeuroprotectionDietEndocrinologychemistryFatty Acids UnsaturatedDementiaFood SciencePolyunsaturated fatty acidFood Research International
researchProduct

Nonsteroidal Anti-Inflammatory Drugs and Ectodomain Shedding of the Amyloid Precursor Protein

2008

<i>Background:</i> Epidemiological studies have suggested that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of Alzheimer’s disease (AD). Several mechanisms have been proposed to explain these findings including increased shedding of the soluble ectodomain of the amyloid precursor protein (sAPP), which functions as a neurotrophic and neuroprotective factor in vitroand in vivo. <i>Objective:</i> To clarify whether NSAIDs consistently stimulate sAPP secretion. <i>Methods:</i> 293-EBNA cells with stable overexpression of an APP-alkaline phosphatase fusion protein (APP-AP), SH-SY5Y and PC12 cells or prim…

medicine.medical_specialtyMedizinische Fakultät -ohne weitere Spezifikation-IndomethacinIbuprofenStimulationCHO Cells-PC12 CellsNeuroprotectionCell LineAmyloid beta-Protein PrecursorNeuroblastomaCricetulusWestern blotDownregulation and upregulationCell Line TumorCricetinaeInternal medicinemedicineAmyloid precursor proteinAnimalsddc:610medicine.diagnostic_testbiologyChemistryAnti-Inflammatory Agents Non-SteroidalTransfectionAlkaline PhosphataseRatsKineticsEndocrinologyNeurologyEctodomainCell culturebiology.proteinTetradecanoylphorbol AcetateNeurology (clinical)
researchProduct

Practical importance of neuroprotection in Parkinson's disease.

2003

Consensus could be reached that there is overwhelming evidence of preclinical neuroprotection. However, the evidence of neuroprotection/neurorescue under clinical conditions is limited. Lessons from clinical trials designed to show neuroprotection (selegiline, amantadine, dopamine agonists) demonstrate that with the drugs available neuroprotection/neurorescue has to start as early as possible. A PET-controlled clinical trial with ropinirole shows that there seems to be a good chance for neuroprotection in the early phase of Parkinson's disease in patients treated from the very beginning of the disease while there is no such benefit in patients with a late start of a neuroprotective therapeu…

medicine.medical_specialtyNeurologyParkinson's diseaseIndolesBioinformaticsNeuroprotectionAntiparkinson AgentsDegenerative diseaseSelegilineAmantadineMedicineHumansbusiness.industrySelegilineAmantadineParkinson Diseasemedicine.diseaseClinical trialRopiniroleNeuroprotective AgentsNeurologyDopamine AgonistsNeurology (clinical)businessNeurosciencemedicine.drugJournal of neurology
researchProduct

A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes

2010

Recent findings suggest that neuronal pathology occurs early in the course of multiple sclerosis and seems to be responsible for accumulation of disability. Nonetheless, the nervous system has an intrinsic potential for repair and compensation in the neuronal component. Disease-modifying drugs such as glatiramer acetate interfere with, and down-regulate, inflammatory pathology and slow neurodegeneration. Moreover, certain regulatory cytokines and neurotrophic factors have the capacity to promote neuronal and axonal repair. Given the importance of neuronal injury in multiple sclerosis and the potential of certain treatments for neuronal repair, it is important to possess adequate and sensiti…

medicine.medical_specialtyPathologyMultiple SclerosisNeuroprotectionNeurotrophic factorsmedicineHumansGlatiramer acetateNeuronsmedicine.diagnostic_testbusiness.industryMultiple sclerosisNeurodegenerationBrainMagnetic resonance imagingAnatomical pathologymedicine.diseaseMagnetic Resonance ImagingAxonsnervous systemNeurologyNeurology (clinical)businessNeuroscienceDiffusion MRImedicine.drugJournal of the Neurological Sciences
researchProduct

Improved Regeneration of Autologous Nerve Transplants by Means of VEGF-Gene Therapy

2009

The impact of the Vascular Endothelial Growth Factor (VEGF) on the angiogenic cascade is proven. Recently its neuroprotective effect after peripheral nerve injuries on α-motoneurons in the spinal cord was shown. Experiments on α-motoneurons demonstrated a decreased sensitivity to ischemia under VEGF-therapy. Aim of the study was to elucidate the effect of a localized VEGF-gene-therapy using an adenoviral vector construct in the model of a peripheral nerve defect in the rat treated with an autologous nerve transplant.

medicine.medical_specialtyPathologybiologybusiness.industryGenetic enhancementRegeneration (biology)VEGF receptorsIschemiamedicine.diseaseSpinal cordNeuroprotectionSurgeryViral vectorVascular endothelial growth factorchemistry.chemical_compoundmedicine.anatomical_structurechemistrymedicinebiology.proteinSurgerybusinessJournal of Plastic, Reconstructive & Aesthetic Surgery
researchProduct

Practical recommendations for the application of DE 59/2013

2019

The changes introduced with Council Directive 2013/59/Euratom will require European Member States adapt their regulations, procedures and equipment to the new high standards of radiation safety. These new requirements will have an impact, in particular, on the radiology community (including medical physics experts) and on industry. Relevant changes include new definitions, a new dose limit for the eye lens, non-medical imaging exposures, procedures in asymptomatic individuals, the use and regular review of diagnostic reference levels (including interventional procedures), dosimetric information in imaging systems and its transfer to the examination report, new requirements on responsibiliti…

medicine.medical_specialtyPopulationRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciencesDose limit0302 clinical medicineOccupational ExposureLens CrystallinemedicineHumansRadiology Nuclear Medicine and imagingMedical physicsEuropean UnionEye lenseducationBSSEuropean Directive EuratomRadiodiagnostic and radiotherapeutic proceduresMedical exposureRadiation protectioneducation.field_of_studymedicine.diagnostic_testbusiness.industryMember statesInterventional radiologyGeneral MedicineRadiation ExposureReference StandardsDirective030220 oncology & carcinogenesisRadiological weaponAccidentalAsymptomatic DiseasesEmergenciesSafetyRadiologybusinessHealth PhysicsLa radiologia medica
researchProduct

An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage

2004

Cerebral vasospasm and the resulting cerebral ischemia occurring after subarachnoid hemorrhage (SAH) are still responsible for the considerable morbidity and mortality in patients affected by cerebral aneurysms. Mechanisms contributing to the development of vasospasm, abnormal reactivity of cerebral arteries and cerebral ischemia after SAH have been intensively investigated in recent years. It has been suggested that the pathogenesis of vasospasm is related to a number of pathological processes, including endothelial damage, smooth muscle cell contraction resulting from spasmogenic substances generated during lyses of subarachnoid blood clots, changes in vascular responsiveness and inflamma…

medicine.medical_specialtyPotassium ChannelsSubarachnoid hemorrhageCerebral arteriesIschemiaNeuroprotectionCerebral vasospasmInternal medicinemedicineAnimalsHumansNitric Oxide Donorscardiovascular diseasesErythropoietinVascular diseasebusiness.industryEndothelinsGeneral NeuroscienceVasospasmSubarachnoid Hemorrhagemedicine.diseaseRecombinant Proteinsnervous system diseasesCerebrovascular DisordersErythropoietinAnesthesiaCardiologyNeurology (clinical)businessmedicine.drugBrain Research Reviews
researchProduct

Radiation exposure in CT-guided interventions.

2013

To investigate radiation exposure in computed tomography (CT)-guided interventions, to establish reference levels for exposure, and to discuss strategies for dose reduction.We analyzed 1576 consecutive CT-guided procedures in 1284 patients performed over 4.5 years, including drainage placements; biopsies of different organs; radiofrequency and microwave ablations (RFA/MWA) of liver, bone, and lung tumors; pain blockages, and vertebroplasties. Data were analyzed with respect to scanner settings, overall radiation doses, and individual doses of planning CT series, CT intervention, and control CT series.Eighty-five percent of the total radiation dose was applied during the pre- and post-interv…

medicine.medical_specialtyPsychological interventionComputed tomographyRadiation DosageRadiography InterventionalGermanymedicineHumansRadiology Nuclear Medicine and imagingRadiometrymedicine.diagnostic_testbusiness.industryRadiation doseInterventional radiologyGeneral MedicineEnvironmental ExposureRadiation exposureSurgery Computer-AssistedBody BurdenDose reductionRadiologyRadiation protectionNuclear medicinebusinessImage-Guided BiopsyTomography X-Ray ComputedEnvironmental MonitoringEuropean journal of radiology
researchProduct

[Insight on how to assess and improve the response to the COVID-19 pandemic].

2022

Resumen: La pandemia de COVID-19 ha afectado de manera particularmente intensa a España, pese a su nivel de desarrollo y la elogiada solidez de su Sistema Nacional de Salud. Para comprender qué ha pasado e identificar cómo mejorar la respuesta creemos imprescindible una evaluación independiente multidisciplinaria de la esfera sanitaria, política y socioeconómica. En este trabajo proponemos objetivos, principios, metodología y dimensiones a evaluar, además de esbozar el tipo de resultados y conclusiones esperadas. Nos inspiramos en los requerimientos formulados por el panel independiente de la Organización Mundial de la Salud y en las experiencias evaluativas en otros países, y detallamos la…

medicine.medical_specialtyPublic PolicyDeterminantes sociales de saludPolicy responsesSocial determinants of health03 medical and health sciences0302 clinical medicineRespuestas políticasPrevención y controlmedicineHealth services researchHumans030212 general & internal medicineSocial determinants of healthEconomic impact analysisEvaluationPandemicsPandemiaPandemicScope (project management)EvaluaciónSARS-CoV-2030503 health policy & servicesCorporate governancePublic healthPublic Health Environmental and Occupational HealthHealth services researchCOVID-19Investigación sobre servicios de saludPrevention and controlSocial protectionRisk analysis (engineering)PreparednessPublic HealthBusinessPublic aspects of medicineRA1-12700305 other medical science
researchProduct